Research programme: temozolomide/thalidomide nanoparticles - Pharmaco-KinesisAlternative Names: Temozolomide/thalidomide; Thalidomide/temozolomide
Latest Information Update: 02 Jul 2015
At a glance
- Originator Pharmaco-Kinesis Corporation
- Class Imidazoles; Phthalimides; Piperidones; Small molecules; Triazenes
- Mechanism of Action Alkylating agents; Angiogenesis inhibitors; DNA cross linking agents; DNA synthesis inhibitors; Tumour necrosis factor inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Glioma
Most Recent Events
- 26 May 2015 Preclinical trials in Glioma in USA (Parenteral)
- 30 Apr 2013 Early research in Glioma in USA (Parenteral)